Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan F Ascaso

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 11, 2010
[Advances in cholesterol-lowering interventions]Juan F Ascaso
Medicina Clinica|August 14, 2013
[Type 2 diabetes mellitus: new treatments]Juan F Ascaso
Medicina Clinica|January 5, 2010
[Global therapy of diabetic dyslipidemia: benefits and new therapeutic approaches]Rafael Carmena, Juan F Ascaso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 2, 2019
Control of the overall lipid profileMariano Blasco, Juan F Ascaso,
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 14, 2015
[Importance of dyslipidaemia in cardiovascular disease: a point of view]Juan F Ascaso, Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Lipid metabolism and classification of hyperlipaemiasJosé T Real, Juan F Ascaso
Journal of Hypertension|July 11, 2020
Chronic kidney disease as a cardiovascular risk factorRafael Carmena, Juan F Ascaso, Josep Redon
Diabetes Technology & Therapeutics|June 15, 2011
Basal plus basal-bolus approach in type 2 diabetesF Javier Ampudia-Blasco, Paolo Rossetti, Juan F Ascaso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 18, 2023
Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?Sergio Martínez-Hervás, José T Real, Rafael Carmena, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 12, 2015
[Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)]Juan F Ascaso, Pedro Mata, Cristina Arbona, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 11, 2010
[Advances in cholesterol-lowering interventions]Juan F Ascaso
Medicina Clinica|August 14, 2013
[Type 2 diabetes mellitus: new treatments]Juan F Ascaso
Medicina Clinica|January 5, 2010
[Global therapy of diabetic dyslipidemia: benefits and new therapeutic approaches]Rafael Carmena, Juan F Ascaso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 2, 2019
Control of the overall lipid profileMariano Blasco, Juan F Ascaso,
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 14, 2015
[Importance of dyslipidaemia in cardiovascular disease: a point of view]Juan F Ascaso, Rafael Carmena
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Lipid metabolism and classification of hyperlipaemiasJosé T Real, Juan F Ascaso
Journal of Hypertension|July 11, 2020
Chronic kidney disease as a cardiovascular risk factorRafael Carmena, Juan F Ascaso, Josep Redon
Diabetes Technology & Therapeutics|June 15, 2011
Basal plus basal-bolus approach in type 2 diabetesF Javier Ampudia-Blasco, Paolo Rossetti, Juan F Ascaso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 18, 2023
Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?Sergio Martínez-Hervás, José T Real, Rafael Carmena, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 12, 2015
[Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)]Juan F Ascaso, Pedro Mata, Cristina Arbona, et al.
Pageof 9